Innospec Inc.
NASDAQ:IOSPChemicals - Specialty
+$0.08 today
- Market cap
- $1.94B
- Beta
- 0.91
- P/E (TTM)
- 18.0
- EPS (TTM)
- $4.61
- Dividend yield
- 2.15%
Volume 0.23M
Average 0.24M
IOSP Net Income
Bottom-line profit after all expenses, interest, and taxes.
Innospec Inc.NASDAQ: IOSP
Net Income · Q2 FY2026 · quarter ended Jun 2026
Net income grows, but more slowly than its trailing trend
Q2 FY2026 net income of $30.8M rose 31.1% year over year, behind the +529.5% change in trailing-twelve-month net income. Sequentially, it rose 1.3% from the prior quarter. Over 3 fiscal years it compounded at -4.3% a year.
Context
- Net income amounted to 6.6% of revenue in FY2025, up 4.6 pp from a year earlier.
- Net income increased in 2 of the last 3 fiscal years.
What to watch
Whether net income reaches the consensus estimate from 2 analysts of $125.92M (+8.0%) for the fiscal year ending Dec 2026, a slowdown from the +227.5% reported in FY2025.
Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.
- Latest quarterJun 2026
- $30.8M+1.3% QoQ
- Last fiscal yearDec 2025
- $116.6M+227.5% YoY
- LTMJun 2026
- $121.5M+529.5% YoY
| Horizon | Past | Forecast | Difference |
|---|---|---|---|
| Quarter | +31.1% | +141.7% | +110.6 pp |
| 1 year | +227.5% | +8.0% | -219.5 pp |
| 3-year CAGR | -4.3% | +13.0% | +17.3 pp |
| 5-year CAGR | — | — | |
| 10-year CAGR | — | — |
Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.
Net Income history
USD · from the income statement
- Latest · FY2025
- 116.6M USD
- Year-over-year change
- +227.5%
- 4-year CAGR
- +5.8%
| Period | Period end | Net Income | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 116.6M | +227.5% |
| FY2024 | 2024-12-31 | 35.6M | -74.4% |
| FY2023 | 2023-12-31 | 139.1M | +4.6% |
| FY2022 | 2022-12-31 | 133M | +42.9% |
| FY2021 | 2021-12-31 | 93.1M | — |
Net Income vs competitors
How IOSP compares with its peers on the latest reported figures
- IOSP's LTM Jun 2026 net income of $121.5M is the 5th highest of the 10 companies compared; the peer median is $97.18M.
- Its year-over-year change of +529.5% is the 2nd highest of 10, against a peer median of -9.8%.
- Net income amounts to 6.6% of revenue for IOSP, versus a peer median of 5.2%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Jun 2026 | $442M | -46.9% | -15.8% | 5.0% | |
| LTM Jun 2026 | $433.37M | -9.8% | +14.4% | 15.8% | |
| LTM Aug 2026 | $197.76M | +72.2% | -5.5% | 5.6% | |
| LTM Jun 2026 | $190M | -55.3% | +16.6% | 5.2% | |
| LTM Jun 2026 | $121.5M | +529.5% | -4.3% | 6.6% | |
| LTM Sep 2026 | $97.18M | +1179.4% | — | 4.8% | |
| LTM Sep 2026 | $85.81M | +3.2% | +10.7% | 7.5% | |
| LTM Jun 2026 | $52M | +106.0% | — | 2.8% | |
| LTM Mar 2026 | -$52.34M | -656.2% | — | 47.5% | |
| LTM Sep 2026 | -$193.8M | -421.0% | — | 3.7% | |
| Peer median (excluding IOSP) | $97.18M | -9.8% | +10.7% | 5.2% | |
Competitors are the stored peer set for IOSP. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 1.48B | 1.96B | 1.95B | 1.85B | 1.78B |
| Cost of Revenue | 1.05B | 1.38B | 1.36B | 1.3B | 1.29B |
| Gross Profit | 434.9M | 586.7M | 591.1M | 542.9M | 492.4M |
| Gross Margin | 29.3% | 29.9% | 30.3% | 29.4% | 27.7% |
| Research & Development | 37.4M | 38.7M | 41.7M | 47.8M | 51M |
| Selling, General & Admin | 267.2M | 360.7M | 387.8M | 314M | 285.1M |
| Operating Expenses | 302.8M | 399.4M | 429.5M | 365M | 336.1M |
| Depreciation & Amortization | 42.7M | 40.1M | 39.3M | 43.5M | 43.6M |
| EBITDA | 173M | 225.8M | 213.7M | 224.6M | 181.7M |
| EBITDA Margin | 11.7% | 11.5% | 11.0% | 12.2% | 10.2% |
| Operating Income | 132.1M | 187.3M | 161.6M | 177.9M | 156.3M |
| Operating Margin | 8.9% | 9.5% | 8.3% | 9.6% | 8.8% |
| Interest Income | 0 | 0 | 0 | 0 | 9.2M |
| Interest Expense | 1.5M | 1.1M | 0 | 0 | 0 |
| Other Income / Expenses | 2.3M | (2.7M) | 12.8M | (136.7M) | (18.2M) |
| Income Before Tax | 134.4M | 184.6M | 174.4M | 41.2M | 138.1M |
| Pre-Tax Margin | 9.1% | 9.4% | 8.9% | 2.2% | 7.8% |
| Income Tax Expense | 41.3M | 51.6M | 35.3M | 5.6M | 21.5M |
| Net Income | 93.1M | 133M | 139.1M | 35.6M | 116.6M |
| Net Margin | 6.3% | 6.8% | 7.1% | 1.9% | 6.6% |
| EPS (Basic) | 3.78 | 5.37 | 5.60 | 1.43 | 4.69 |
| EPS (Diluted) | 3.75 | 5.32 | 5.56 | 1.42 | 4.67 |
| Weighted Avg Shares | 24.65M | 24.79M | 24.85M | 24.93M | 24.88M |
| Weighted Avg Shares (Diluted) | 24.85M | 24.98M | 25.02M | 25.12M | 24.99M |
Innospec Inc.
NASDAQ:IOSP
Intrinsic Alpha fair value
Locked
Current Price
$78.86
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.